AbbVie, Inc. (ABBV)
229.25
-6.94
(-2.94%)
USD |
NYSE |
Mar 05, 12:00
AbbVie Cash from Investing (Quarterly) : -1.463B for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -693.00M |
| Biogen, Inc. | -1.232B |
| Gilead Sciences, Inc. | -1.835B |
| Johnson & Johnson | -4.485B |
| Eli Lilly & Co. | -2.802B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.218B |
| Cash from Financing (Quarterly) | -4.166B |
| Free Cash Flow | 17.82B |
| Free Cash Flow Per Share (Quarterly) | 2.756 |
| Free Cash Flow to Equity (Quarterly) | 5.447B |
| Free Cash Flow to Firm (Quarterly) | 5.404B |
| Free Cash Flow Yield | 4.39% |